admin

The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to announce a significant milestone in industry diversification. An IPO of Rs 1–2 Billion has been approved for a specialized Veterinary Subsidiary, dedicated to expanding veterinary pharmaceutical manufacturing. This move marks a strategic shift toward internal growth and investment, ensuring that Pakistan’s pharma sector remains a versatile

The PPMA is proud to highlight the growing bilateral trade relationship between Pakistan and Cambodia. As we look toward the Joint Trade Committee meeting, pharmaceuticals remain a top priority for export cooperation and economic growth. Paving the way for global healthcare excellence.

We are pleased to report that more than 80% of missing medicines have been restored to the market. Price deregulation has paved the way for better availability, ensuring that the right treatment is there when you need it most. Together with the PPMA, we’re working toward a healthier, more resilient Pakistan.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) extends its heartfelt congratulations to Prime Minister Mian M. Shehbaz Sharif and Federal Health Minister Syed Mustafa Kamal on the conferment of the first-ever Prime Minister’s Recognition Award upon the Drug Regulatory Authority of Pakistan (DRAP). This award recognizes the landmark regulatory reforms and end-to-end automation that have transformed

Big news for the industry! Uzbekistan has announced a 10-year tax holiday for Pakistani traders to boost pharmaceutical cooperation and investment. This is a massive win for bilateral trade and a testament to the growing influence of Pakistan’s pharma sector on the global stage.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to spearhead a new era of collaboration between Pakistan and the Philippines. With a shared vision to hit a $1 Billion trade target, we are focusing our efforts on what matters most: accessible medicines, life-saving vaccines, and robust local manufacturing.

Pakistan’s pharmaceutical and medical device exports have surged by 34%, marking a significant breakthrough in the country’s industrial footprint. This growth trajectory is a direct result of strategic structural shifts designed to compete on a global scale.